SCHEMBL4841551

SCHEMBL4841551

COCCN1C(=O)[C@H](N)CC=C[C@H]1c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
CYP2C9 P11712 1/20 0.37
MAPT P10636 1/20 0.37
RECQL P46063 1/20 0.37
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
GAA P10253 1/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36
FPR1 P21462 1/20 0.36
ALOX15 P16050 1/20 0.35
KDM4E B2RXH2 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KDM1A O60341 1/20 0.34
MAPK1 P28482 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5795559 1.00 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2LMNAFNTAFNTB
SCHEMBL4841082 1.00 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2LMNAFNTAFNTB
SCHEMBL4843406 0.80 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2LMNAFNTAFNTB
SCHEMBL14254617 0.80 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2LMNAFNTAFNTB
SCHEMBL5792149 0.80 MEN1 (0.36) ALDH1A1SMN1; SMN2LMNAMAPTRECQL
SCHEMBL4845496 0.80 MEN1 (0.36) ALDH1A1SMN1; SMN2LMNAMAPTRECQL
SCHEMBL5791105 0.79 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MAPTKMT2AMEN1
SCHEMBL4839870 0.79 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MAPTKMT2AMEN1
SCHEMBL4843507 0.79 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MAPTKMT2AMEN1
SCHEMBL4841214 0.78 TSHR (0.38) ALDH1A1LMNAMAPTKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342007-B2 Lactams and uses thereof ASTRAZENECA AB (SE) 2008-03-11 US disclosed
US-7342007-B2 Lactams and uses thereof ASTRAZENECA AB (SE) 2008-03-11 US disclosed
US-7342007-B2 Lactams and uses thereof ASTRAZENECA AB (SE) 2008-03-11 US disclosed
US-20060183732-A1 Novel lactams and uses thereof ASTRAZENECA AB (SE) 2006-08-17 US disclosed
WO-2004080983-A1 NOVEL LACTAMS AND USES THEREOF ASTRAZENECA AB (SE) 2004-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183732-A1 Novel lactams and uses thereof BACE1, BACE2, APP ALDH1A1 2419/4885SMN1; SMN2 975/4885LMNA 2273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.